Medical marijuana patient and double lung transplant candidate Vey Linville discusses using marijuana to treat his severe emphysema and tells the truth about dispensaries in San Diego, the recent federal crackdown in California, and his efforts in Imperial Beach.
Posted By The Health Cure, December 16 2017
Questions After Presentation With Brian From The Health Cure Serbia, Belgrade, Novi Sad May 4th and 5th 2015
Dani Kanabisa: Lečenje kanabisom, sa predavanja Brajana Keta (Bryan Ket, Holland) u Beogradu i Novom Sadu, 4 i 5 maja 2015.
Seminar ‘Healing with cannabis’: Guest, Bryan Ket (Holland). In Belgrade and Novi Sad on 4th and 5th May, 2015. Questions and answers.
Pitanja bolesnih, članova porodica i odgovori.
Interesovanje je bilo daleko veće nego što su prostori to dozvoljavali, dosta se saznalo, razmenila su se iskustva, najnovija naučno-mdicinska saznanja i svi bolesni su otišli sa realnom nadom u izlečenje.
Ima previše dokaza iz nauke i medicine, ima previse živih svedoka sa svojom medicinskom dokumentacijom i previše bolesnih koji čekaju lek, previše njih koji umiru i očekuju da im odgovorni ljudi koji su izabrani, što je moguće pre omoguće da se leče kanabisom i ekstraktima njegovih cvetova.
Vreme čekanja je isteklo. Dnevno u Srbiji umre preko 70 osoba od kancera, dok preko 110 njih oboli, pretežno mladih. Nama je neophodan lek, onaj koji nam zaista pomaže – KANABIS.
IRKA su ljudi, obični, bolesni, solidarni. Rešili smo da pomognemo jedni drugima.
Irka se bavi obrazovanjem, istinom, naukom, nas interesuju jedino bolesni i dobrobit svih građana Srbije. Privatnom interesu, biznisu, farmaciji, mafiji, ne treba dozvoliti da utiče na lečenje i osnovna ljudska prava.
Ovo je naša zemlja i naše pravo na LEK i izbor!
Pošaljite nam vašu medicinsku dokumentaciju za zajednički zahtev obolelih za lečenje kanabisom, Skupštini, Ministarstvu zdravlja i Vladi Srbije: firstname.lastname@example.org
Potvrda o saglasnosti da smemo da koristimo vašu medicinsku dokumentaciju za zajednički zahtev: http://irka.org.rs/potrebna-nam-je-va…
I posle 2 sata razgovora je bilo prepuno a pitanja i razmena iskustava i znanja su se nastavili i kasnije u bašti kafea do kasno u noć.
Click on the video to watch.
Kada bi svaki dan pravili tribine i radionice bilo bi sve više i više ljudi koji žele da saznaju i koji svedoče javno o svom lečenju kanabisom i ekstraktima cvetova.
Tribina Lečenje kanabisom, Brajan Ket (Holandija) Novi Sad 5. maj 2015
Click on the video to watch.
Lečenje kanabisom i kancer, sa predavanja Brajana Keta u Beogradu
Paula Doyle-Weigel is a registered nurse from Medicine Hat, Alberta, Canada. She was diagnosed with breast cancer 4 years ago and refused conventional treatments,
opting instead for a number of alternative therapies, including cannabis oil.
It took time to find out what worked for her, but today she is cancer free and now she and her husband help others through their own clinic.
Posted by The Health Cure, June 1 2017
After recovering from the ‘incurable’ cancer, Miller and his wife moved back to Illinois. He now runs a “compassionate cannabis” program to help others who are struggling like he was.
“What we’re doing is we’re just making small amounts to keep it around and educating others on how to do this,” he said. “Because if you have access to any kind of cannabis, I can give you links on my site to show you how to do this in your own kitchen and save your life.”
Posted By The Health Cure, June 1 2017
The endocannabinoid system or the endogenous cannabinoid system was named after cannabis because the plant led to the discovery of this crucial physiological system. The system is made of up endocannabinoids and cannabinoid receptors, which help regulate many of our most basic functions like sleep and appetite. Endocannabinoids are naturally produced in the body and cannabis consumption increases the amount of endocannabinoids present in the body. The function of endocannabinoids and their receptors is to maintain homeostasis from the organism to the cell level by reversing damage in whatever way possible.
What are cannabinoid receptors?
The CB receptors can be found throughout the body, and there are two main kinds: CB1 and CB2 receptors. CB1 receptors are mostly found in the brain with some present in the lung, kidney, liver, fat, heart, muscle, and bone. CB2 receptors are primarily found in the immune system, and blood cells but both can be found in the same tissues providing different functions. CB1 receptors are mostly responsible for the psychoactive and euphoric effects of THC. On the other hand, CB2 receptors mostly work in the immune system, but they are also present in the liver, gut, muscle, and bone.
Generally speaking the CB1 and CB2 receptors cause healing properties when activated within the areas of the body they are located. Receptors are similar to locks, and the cannabinoids are the keys.The activity of CB1 and two receptors usually reverses the damage done to the body, returning it to homeostasis. This also applies to mental health damage because endocannabinoids can aid in balancing mood and creating euphoria.
The balance between CB1 and CB2 inhibition and activation by cannabinoids is important. Heavy CB1 inhibition may lead to an increased risk of depression, mood disturbance, and immunosuppression. However, if CB1 over-activates there is an increased risk of psychoactivity, systemic inflammation, cardiovascular risk, diabetes, and obesity.
A January 2014 story on a Croatian news station detailed the story of a 38 year old man, referred to as Mark for confidentially reasons, fighting non-small cell lung cancer. He was given four to six months to live, with a maximum of twelve months if fortunate. Mark initially used chemotherapy and radiation, which left him
in a state that “you can not even call human.” His face was destroyed, his upper lip swollen, tissue was
falling off his fingers, and his skin was overly soft. The pain was especially devastating, and three times a day, Mark thought of killing himself. Despite the barrage of conventional treatments, a further medical check revealed the cancer had doubled. After the news, Mark stopped the treatments and began using
cannabis oil. He immediately began feeling better, and earlier pains disappeared. A month into
treatment, Mark began spitting out sizable amounts dark matter which was confirmed as cancerous. After three months, the cancer was no longer visible on X-rays.
The Science of Cannabis as a Treatment for Epilepsy
What to do about the medical use of marijuana (cannabis) as a potential treatment for a number of neurologic conditions, including epilepsy, is a hotly debated issue. There are legal issues surrounding access to cannabis, as well as a lack of scientific research on the usefulness and safety of marijuana as a treatment for seizures. Additionally, many different substances containing cannabis are being used which makes it difficult to study.
Does cannabis help seizures?
Evidence from laboratory studies, anecdotal reports, and small clinical studies from a number of years ago suggests that cannabidiol, a non-psychoactive compound of cannabis, could potentially be helpful in controlling seizures. However, there are conflicting reports in the literature. So far, scientifically controlled studies have not shown definitive proof of the effectiveness and safety of marijuana or cannabis in epilepsy. For example, in 2012, a literature review of clinical studies on cannabinoids for epilepsy could not give a reliable conclusion about the effectiveness of four randomized controlled trials of cannabidiol. Yet in the 48 people included in these reports, no side effects were noted. Conducting studies can be difficult as researchers have limited access to marijuana due to federal regulations and even more limited access to cannabidiol; there are also increased financial and time constraints.
Individual reports of children with refractory (or intractable) epilepsy who have tried cannabis, usually with high ratios of cannabidiol to THC, have reported marked improvements in seizure frequency, including a report describing the results of Charlotte, a girl with Dravet syndrome.
Cannabidiol (CBD): Recently, there have been some open-labeled studies in the U.S. of Epidiolex (a drug derived from cannabidiol or CBD), which is produced by a pharmaceutical company (GW Pharmaceuticals). Epidiolex is a purified, 99% oil-based extract of CBD that is produced to give known and consistent amounts in each dose. The U.S. Food and Drug Administration (FDA) has given some epilepsy centers permission to use this drug as “compassionate use” for a limited number of people at each center. Such studies are ongoing for difficult epilepsies such as Lennox-Gastaut syndrome (in children and adults) and Dravet syndrome in children.
Results from 213 people who received Epidiolex (99% CBD) in an open label study (without a placebo control) were presented at the American Academy of Neurology, April 22, 2015 in Washington DC. Data from 137 people who completed 12 weeks or more on the drug were used to look at how helpful or effective the drug was. People who received the Epidiolex ranged from 2 to 26 years old with an average age of 11. All had epilepsy that did not respond to currently available treatments – 25 or 18% had Dravet Syndrome (DS) and 22 or 16% had Lennox-Gastaut Syndrome (LGS).
Seizures decreased by an average of 54% in 137 people who completed 12 weeks on Epidiolex.
Patients who had DS responded more positively with a 63% decrease in seizures over 3 months.
This improvement in seizures lasted through 24 weeks on the Epidiolex, more often for people with DS than without DS.
In 27 patients with atonic seizures (which are commonly seen in people with LGS as well as other types of epilepsy), the atonic seizures decreased by 66.7% on average.
The responder rate (the number of people whose seizures decreased by at least 50%) was also slightly better in patients with DS (about 55% at 3 months) as compared to patients without DS (50%).
People who were also taking the anti-seizure medication Clobazam (Onfi) seemed to respond more favorably to the Epidiolex with a greater improvement in convulsive seizures than in patients who were not taking Clobazam. The authors suggested that an interaction between Clobazam and Epidiolex may play a part in the differences seen.
14 people withdrew from the study because the drug was not effective for them.
A controlled study on on Epidiolex involving many epilepsy centers is now being done that will compare children with Dravet syndrome or Lennox-Gastaut syndrome taking the active drug with children not receiving the drug.
The Health Cure, December 12 2016
Medicinal Marijuana, Cannabis Oil, THC Oil, CBD Oil, Rick Simpson, Phoenixtears, Run From The Cure, The Health Cure, CB1, CB2 Receptors, Cannabis Cures Cancer, Epileptic, Seizures, Skincancer, Alzheimer, Glaucoma, Artitis, Endocannabinoid system, www.thehealthcure.org, Indiga, Sativa, Doggs, Cats, Clearing The Smoke